BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19895736)

  • 1. [Correlation of XPD gene with susceptibility to gastric cancer].
    Zhang CZ; Chen ZP; Xu CQ; Ning T; Li DP; Hou RP
    Ai Zheng; 2009 Nov; 28(11):1163-7. PubMed ID: 19895736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selected genetic polymorphisms in xeroderma pigmentosum complementary group D on gastric cancer.
    Chen Z; Zhang C; Xu C; Li K; Hou R; Li D; Cheng X
    Mol Biol Rep; 2011 Mar; 38(3):1507-13. PubMed ID: 20842450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotype to Gastric Cancer Risk in Taiwan.
    Ji HX; Chang WS; Tsai CW; Wang JY; Huang NK; Lee AS; Shen MY; Chen WY; Chiang YC; Shih TC; Hsu CM; Bau DT
    Anticancer Res; 2015 Sep; 35(9):4975-81. PubMed ID: 26254397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India.
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Urology; 2009 Mar; 73(3):675-80. PubMed ID: 19041121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma.
    Hsieh YY; Chang CC; Bau DT; Yeh LS; Tsai FJ; Tsai CH
    Fertil Steril; 2008 Oct; 90(4 Suppl):1417-23. PubMed ID: 18177646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Repair Gene XRCC1 and XPD Polymorphisms and Gastric Cancer Risk: A Case-Control Study Outcome from Kashmir, India.
    Nissar B; Kadla SA; Khan NS; Shah IA; Majid M; Afshan FU; Ganai BA
    Anal Cell Pathol (Amst); 2018; 2018():3806514. PubMed ID: 30225185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
    Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
    Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and haplotype associations of XPD Lys751Gln, XRCC1 Arg280His and XRCC1 Arg399Gln polymorphisms with nasopharyngeal carcinoma in the Malaysian population.
    Visuvanathan S; Chong PP; Yap YY; Lim CC; Tan MK; Lye MS
    Asian Pac J Cancer Prev; 2014; 15(6):2747-51. PubMed ID: 24761895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population, China.
    Long XD; Ma Y; Huang YZ; Yi Y; Liang QX; Ma AM; Zeng LP; Fu GH
    Mol Carcinog; 2010 Jun; 49(6):611-8. PubMed ID: 20232359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [p53 Codon 72 and 16-bp duplication polymorphisms of gastric cancer in Koreans].
    Kim JM; Lee OY; Lee CG; Kwon SJ; Kim KS; Moon W; Koh DH; Lee HL; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH
    Korean J Gastroenterol; 2007 Nov; 50(5):292-8. PubMed ID: 18159160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair genes XPD and XRCC1 polymorphisms and risk of end-stage renal disease in Egyptian population.
    Radwan WM; Elbarbary HS; Alsheikh NM
    Ren Fail; 2015 Feb; 37(1):122-8. PubMed ID: 25310768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.
    Costa S; Pinto D; Pereira D; Vasconcelos A; Afonso-Lopes C; Osório T; Lopes C; Medeiros R
    Cancer Lett; 2007 Feb; 246(1-2):324-30. PubMed ID: 16677755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
    Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
    Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
    Ye W; Kumar R; Bacova G; Lagergren J; Hemminki K; Nyrén O
    Carcinogenesis; 2006 Sep; 27(9):1835-41. PubMed ID: 16571649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration.
    Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
    Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
    Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gln/Gln genotype of XPD codon 751 as a genetic marker for melanoma risk and Lys/Gln as an important predictor for melanoma progression: a case control study in the Swedish population.
    Kertat K; Rosdahl I; Sun XF; Synnerstad I; Zhang H
    Oncol Rep; 2008 Jul; 20(1):179-83. PubMed ID: 18575735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.
    Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT
    Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.